2025 European Society for Medical Oncology (ESMO)
From October 17, 2025 to October 21, 2025
Visit Summit: #4053
Berlin, Germany
Presidential Symposium
- Session: Presidential Symposium II – #3035; Phase III Study of Ivonescimab plus chemotherapy versus Tislelizumab plus chemotherapy as First-line Treatment for advanced squamous non-small cell lung cancer (HARMONi-6)
- Session Date and Time: Sunday, Oct 19, 2025, 16:30 PM – 18:15 PM (CEST) or 7:30 am – 9.15 am (PST)
- Room: Berlin Auditorium – Hub 27
- Presenting Author: Dr. Shun Lu